Ernst & Young recently recognized Florida as one of the fastest growing states in the life science industry and among the top 10 U.S. biotechnology centers. Florida’s economy has long been known for agriculture, tourism, defense, aerospace, real estate and financial services. However, there are currently more than 120 biotech research and development companies in the state excelling in the areas of biological devices, diagnostics and therapeutics.Just a few years ago the state did not rank in the top 10. Now Florida is positioned to leverage these these companies and their capacity for innovation to compete more heavily for business, industry and entrepreneurial strength.Governor Charlie Crist released a report in October by the Task Force on the Study of Biotech Competitiveness. The Task Force hosted several discussions that focused on growing and improving an environment that will foster the development of Florida’s biotechnology economy. The Task Force’s final recommendations identified three key areas of focus—Entrepreneurship, Growing Florida’s Existing Biotech Industry and Recruiting Biotech Companies to Florida. These recommendations can give Florida a competitive edge during a time when existing biotech hubs are competing for limited resources. Now legislative action, implementation and resources will be needed to take advantage of these recommendations and continue the momentum in developing Florida biotech economy. Read the Full Report